代理终点 - 将临床试验和真实世界数据相结合
Maxim Kryukov1, Kathleen P Moriarty2, Macarena Villamea3
1Data & Computational Science, R&D, Sanofi, Barcelona, Spain.
Journal of biomedical informatics
|September 19, 2024
概括
我们开发了一种新方法,通过创建代理模型,在真实世界数据 (RWD) 中估计疾病严重程度. 这使得使用电子健康记录在更大患者群体中更好地评估药物疗效.
科学领域:
- 生物医学信息学 生物医学信息学
- 健康 数据科学 数据科学
- 临床试验分析
背景情况:
- 随机对照试验 (RCT) 使用特定疾病严重程度的终点来监测治疗效果.
- 现实世界数据 (RWD) 往往缺乏这些精确的终点,限制了其在较大人群中用于药物疗效评估的使用.
研究的目的:
- 开发一种方法来学习RWD中疾病终点的代理模型.
- 为了使RWD能够用于评估更广泛的患者群体的药物疗效.
主要方法:
- 通过使用RCT数据的多阶段学习框架开发了一种组合技术.
- 特征选择确定了RWD中存在的重要疾病驱动因素.
- 使用可解释提升机 (EBM) 来创建可解释的代理模型,捕捉非线性关系.
主要成果:
- 这种方法在类风湿性关节炎 (RA) 和亚托皮性皮肤炎 (AD) 上得到了证明.
- 综合特征选择和预测方法在两种疾病中表现强.
- 结果改进了现有的预测疾病严重程度评分的方法.
结论:
- 随着时间的推移,精确的疾病严重程度跟踪对于患者的理解和管理至关重要.
- 该框架使RA和AD的新应用成为可能,包括治疗效果估计和RWD的预后评分.
- 该方法可扩展到其他疾病,其严重程度在电子健康记录中表现不佳.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K


